EGFR c.2238_2256del ;(p.E746Dfs*14)

Variant ID: 7-55242468-AATTAAGAGAAGCAACATCT-A

NM_005228.3(EGFR):c.2238_2256del;(p.E746Dfs*14)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.

Plos One
de Biase, Dario D; Genestreti, Giovenzio G; Visani, Michela M; Acquaviva, Giorgia G; Di Battista, Monica M; Cavallo, Giovanna G; Paccapelo, Alexandro A; Cancellieri, Alessandra A; Trisolini, Rocco R; Degli Esposti, Roberta R; Bartolini, Stefania S; Pession, Annalisa A; Tallini, Giovanni G; Brandes, Alba A AA
Publication Date: 2017

Variant appearance in text: EGFR: 2238_2256del
PubMed Link: 28520821
Variant Present in the following documents:
  • Main text
  • pone.0177822.pdf
View BVdb publication page